Literature DB >> 8383704

Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure.

K Kiuchi1, R P Shannon, K Komamura, D J Cohen, C Bianchi, C J Homcy, S F Vatner, D E Vatner.   

Abstract

The development of pacing-induced heart failure was studied in chronically instrumented, conscious dogs paced at a rate of 240 beats/min for 1 d (n = 6), 1 wk (n = 6), and 3-4 wk (n = 7). Left ventricular (LV) dP/dt was decreased (P < 0.0125) at 1 d, LV end-diastolic pressure and heart rate were increased (P < 0.0125) at 1 wk, but clinical signs of heart failure were only observed after 3-4 wk of pacing. Plasma norepinephrine rose (P < 0.0125) after 1 d of pacing, whereas LV norepinephrine was reduced (P < 0.0125) only after 3-4 wk of pacing. Both the fraction of beta-adrenergic receptors binding agonist with high affinity and adenylyl cyclase activity decreased (P < 0.0125) after 1 d of pacing. Total beta-adrenergic receptor density was not changed at any time point, but beta 1-adrenergic receptor density was decreased (P < 0.0125) after 1 wk. The functional activity of the guanine nucleotide binding protein, Gs, was not reduced, but the Gi alpha 2 isoform of the alpha subunit of the GTP-inhibitory protein rose after 3-4 wk of pacing. Thus, myocardial beta-adrenergic signal transduction undergoes change shortly (1d) after the initiation of pacing, before heart failure develops. The mechanism of beta-adrenergic receptor dysfunction in pacing-induced heart failure is characterized initially by elevated plasma levels of catecholamines, uncoupling of beta-adrenergic receptors, and a defect in the adenylyl cyclase catalytic unit. Selective down-regulation of beta 1-adrenergic receptors, increases in Gi alpha 2, and decreases in myocardial catecholamine levels occur as later events.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383704      PMCID: PMC288043          DOI: 10.1172/JCI116312

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE.

Authors:  C A CHIDSEY; E BRAUNWALD; A G MORROW
Journal:  Am J Med       Date:  1965-09       Impact factor: 4.965

2.  Selection of a variant lymphoma cell deficient in adenylate cyclase.

Authors:  H R Bourne; P Coffino; G M Tomkins
Journal:  Science       Date:  1975-02-28       Impact factor: 47.728

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Plasma norepinephrine in congestive heart failure.

Authors:  J A Thomas; B H Marks
Journal:  Am J Cardiol       Date:  1978-02       Impact factor: 2.778

5.  Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine.

Authors:  J D Peuler; G A Johnson
Journal:  Life Sci       Date:  1977-09-01       Impact factor: 5.037

6.  Defective cardiac parasympathetic control in patients with heart disease.

Authors:  D L Eckberg; M Drabinsky; E Braunwald
Journal:  N Engl J Med       Date:  1971-10-14       Impact factor: 91.245

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Mechanism of norepinephrine depletion in experimental heart failure produced by aortic constriction in the guinea pig.

Authors:  J F Spann; C A Chidsey; P E Pool; E Braunwald
Journal:  Circ Res       Date:  1965-10       Impact factor: 17.367

9.  Alterations in left ventricular diastolic function in conscious dogs with pacing-induced heart failure.

Authors:  K Komamura; R P Shannon; A Pasipoularides; T Ihara; A S Lader; T A Patrick; S P Bishop; S F Vatner
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

10.  Defect of receptor-cyclase coupling protein in psudohypoparathyroidism.

Authors:  Z Farfel; A S Brickman; H R Kaslow; V M Brothers; H R Bourne
Journal:  N Engl J Med       Date:  1980-07-31       Impact factor: 91.245

View more
  32 in total

1.  Augmenting beta receptors in the heart: short-term gains offset by long-term pains?

Authors:  L E Limbird; D E Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

2.  Down regulation of myocardial beta1-adrenoceptor signal transduction system in pacing-induced failure in dogs with aortic stenosis-induced left ventricular hypertrophy.

Authors:  J Tse; M W Huang; R J Leone; H R Weiss; Y Q He; P M Scholz
Journal:  Mol Cell Biochem       Date:  2000-02       Impact factor: 3.396

Review 3.  Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy.

Authors:  Changwon Kho; Ahyoung Lee; Roger J Hajjar
Journal:  Nat Rev Cardiol       Date:  2012-10-23       Impact factor: 32.419

4.  Overexpression of myocardial Gsalpha prevents full expression of catecholamine desensitization despite increased beta-adrenergic receptor kinase.

Authors:  D E Vatner; K Asai; M Iwase; Y Ishikawa; T E Wagner; R P Shannon; C J Homcy; S F Vatner
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

5.  Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

Authors:  S Engelhardt; L Hein; F Wiesmann; M J Lohse
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

6.  Downregulation of adenylylcyclase types V and VI mRNA levels in pacing-induced heart failure in dogs.

Authors:  Y Ishikawa; S Sorota; K Kiuchi; R P Shannon; K Komamura; S Katsushika; D E Vatner; S F Vatner; C J Homcy
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 7.  Beta-adrenergic receptors in heart failure.

Authors:  P A Insel; H K Hammond
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

8.  Overexpression of Gs alpha protein in the hearts of transgenic mice.

Authors:  C Gaudin; Y Ishikawa; D C Wight; V Mahdavi; B Nadal-Ginard; T E Wagner; D E Vatner; C J Homcy
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Mechanisms of enhanced beta-adrenergic reserve from cardiac resynchronization therapy.

Authors:  Khalid Chakir; Samantapudi K Daya; Takeshi Aiba; Richard S Tunin; Veronica L Dimaano; Theodore P Abraham; Kathryn M Jaques-Robinson; Kathryn Jacques; Edwin W Lai; Karel Pacak; Wei-Zhong Zhu; Rui-ping Xiao; Gordon F Tomaselli; David A Kass
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

10.  Laminin enhances beta(2)-adrenergic receptor stimulation of L-type Ca(2+) current via cytosolic phospholipase A(2) signalling in cat atrial myocytes.

Authors:  M R Pabbidi; X Ji; A M Samarel; S L Lipsius
Journal:  J Physiol       Date:  2009-08-24       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.